Gad65 antigen

Published

dm+d

Unassigned

New Medicines

DiamydType 1 diabetes mellitus; prevention

Information

Diamyd
New molecular entity
Diamyd Medical
Diamyd Medical

Development and Regulatory status

Phase II Clinical Trials
Phase II Clinical Trials
Phase II Clinical Trials
Yes

Category

recombinant human glutamic acid decarboxylase 65 (GAD65)
4 January 2016It is estimated that >1 in 17 people has diabetes (diagnosed or undiagnosed) in UK. In 2013 > 3 million people were diagnosed with diabetes, about 10% of whom had type 1 diabetes. This figure was expected to increase to five million people by 2015 [14].
Type 1 diabetes mellitus; prevention
Subcutaneous